Anti-mouse CD4-InVivo

目录号：A2101         批次号: A210127

       克隆号：GK1.5

打印

Anti-mouse CD4 (克隆号：GK1.5)可与小鼠CD4结合反应。CD4是T细胞受体（TCR）的协同受体，有助于后续与抗原呈递细胞的交流通讯。

抗体信息

克隆号 GK1.5
免疫原

Mouse CTL clone V4
配制 PBS buffer, pH 6.5
推荐同型对照 Rat IgG2b,κ
应用 In vivo CD4+ T cell depletion,FCM,WB
来源 CHO
小鼠病原体检测 all targets tested yielded Negative Results: Theiler’s Murine Encephalomyelitis Virus, Ectromelia (Mousepox) Virus, Hantavirus, Polyomavirus, Sendai Virus, Mycoplasma pulmonis, Pneumonia Virus of Mice, K Virus, Mouse Parvovirus, Mouse Hepatitis Virus, Mouse Norovirus, Mouse Minute Virus, Mouse Cytomegalovirus, Mouse Adenovirus, Lactate Dehydrogenase-Elevating Virus, Reovirus Panel, Lymphocytic Choriomeningitis Virus, Mouse Rotavirus.
储存条件
(自收到货起)		 Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles
除菌 0.2 μM filtered
纯度 99%
蛋白浓度 7.47 mg/ml
内毒素 ＜1EU/mg

客户使用selleck产品的实验数据

Anti-mouse CD4-InVivo在文献中得到引用

HFB301001, an OX40-based immunotherapy, drives Treg clearance and CTL activation through optimized OX40 receptor clustering [ Journal for ImmunoTherapy of Cancer, March 30, 2026, e014185] PubMed: 41912269
Cryoablation Activates the cGAS-STING-CXCL10 Axis in Macrophages to Enhance Anti-Tumor Immunity in NSCLC [ Advanced Science, March 12, 2026, e21931] PubMed: 41818612
HFB301001, an OX40-based immunotherapy, drives Treg clearance and CTL activation through optimized OX40 receptor clustering [ Journal for ImmunoTherapy of Cancer, March 1, 2026, e014185] PubMed: 41912269
DADA Enhances CD8+ T Cell Stemness to Improve Anti‐Tumor Immunity and Immunotherapy Efficacy [ Advanced Science, February 27, 2026, e19765] PubMed: 41758776
Oncolytic adenovirus delivery of neoantigens sensitizes low-mutation tumors to anti-PD-1 therapy and prevents metastasis [ Signal Transduction and Targeted Therapy, December 23, 2025, 410] PubMed: 41429778
Anti-BCL2 therapy eliminates giant congenital melanocytic nevus by senolytic and immune induction [ Signal Transduct Target Ther, 2025, 10(1):161] PubMed: 40374605
LZTR1 regulates epithelial MHC-I expression via NF-κB1 to modulate CD8+ T cells activation [ Cell Discov, 2025, 11(1):84] PubMed: 41162356
Silencing PCSK9 reshapes the spatiotemporal activation of STING for safe and effective cancer immunotherapy [ Nat Commun, 2025, 10.1038/s41467-025-66630-x] PubMed: 41290746
Targeting site-specific N-glycosylated B7H3 induces potent antitumor immunity [ Nat Commun, 2025, 16(1):3546] PubMed: 40229277
BET inhibitor in combination with BCG vaccine enhances antitumor efficacy and orchestrates T cell reprogramming for melanoma [ Cell Rep Med, 2025, 6(3):101995] PubMed: 40107246

禁止用于人体及治疗！